Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Clinical characteristics of patients with CVT
Patient Sex Age (yr) Symptom Duration Conventional Imaging Methods
1 F 47 Headache 2 days TSE, SWI, CE-MRV, TOF-MRV, CT
2 M 19 Headache 10 days TSE, TOF-MRV, CT
3 M 54 Focal neurologic deficit 13 days TSE, SWI, CE-MRV, TOF-MRV, CT
4 M 30 Headache, focal neurological deficit 20 days TSE, CE-MRV, TOF-MRV, CT
5 M 44 Seizures 25 days TSE, TOF-MRV
6 F 53 Headache 27 days TSE, SWI, CE-MRV, TOF-MRV, CT
7 M 42 Headache 1 mo TSE, CE-MRV, TOF-MRV
8 F 32 Headache 1 mo + 22 days TSE, SWI, CE-MRV, TOF-MRV, CT
9 M 19 Headache 2 mo TSE, TOF-MRV, CT
10 F 28 Headache 4 mo TSE, TOF-MRV, CT
11 F 45 Headache, papilledema 4 mo SWI, TOF-MRV, CT
12 F 36 Headache 1 year TSE, CE-MRV, TOF-MRV, CT
13 F 19 Headache 2 days TSE, TOF-MRV, CE-MRV

Patient	Sex	Age (yr)	Symptom	Duration	Conventional Imaging Methods
1	F	47	Headache	2 days	TSE, SWI, CE-MRV, TOF-MRV, CT
2	M	19	Headache	10 days	TSE, TOF-MRV, CT
3	M	54	Focal neurologic deficit	13 days	TSE, SWI, CE-MRV, TOF-MRV, CT
4	M	30	Headache, focal neurological deficit	20 days	TSE, CE-MRV, TOF-MRV, CT
5	M	44	Seizures	25 days	TSE, TOF-MRV
6	F	53	Headache	27 days	TSE, SWI, CE-MRV, TOF-MRV, CT
7	M	42	Headache	1 mo	TSE, CE-MRV, TOF-MRV
8	F	32	Headache	1 mo + 22 days	TSE, SWI, CE-MRV, TOF-MRV, CT
9	M	19	Headache	2 mo	TSE, TOF-MRV, CT
10	F	28	Headache	4 mo	TSE, TOF-MRV, CT
11	F	45	Headache, papilledema	4 mo	SWI, TOF-MRV, CT
12	F	36	Headache	1 year	TSE, CE-MRV, TOF-MRV, CT
13	F	19	Headache	2 days	TSE, TOF-MRV, CE-MRV